{"id":27564,"date":"2025-07-21T19:43:48","date_gmt":"2025-07-21T16:43:48","guid":{"rendered":"https:\/\/www.neolife.com.tr\/?page_id=27564"},"modified":"2025-07-21T20:01:41","modified_gmt":"2025-07-21T17:01:41","slug":"terapija-radioaktivnim-jodom","status":"publish","type":"page","link":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/","title":{"rendered":"Terapija radioaktivnim jodom"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"27564\" class=\"elementor elementor-27564\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-651d7d7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"651d7d7\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-86fa447\" data-id=\"86fa447\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-874ea19 elementor-widget elementor-widget-text-editor\" data-id=\"874ea19\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4 data-start=\"69\" data-end=\"105\"><strong data-start=\"73\" data-end=\"105\">Terapija radioaktivnim jodom<\/strong><\/h4><h4 data-start=\"107\" data-end=\"240\"><strong data-start=\"112\" data-end=\"240\">Terapija radioaktivnim jodom se preporu\u010duje pacijentima sa diferenciranim karcinomom \u0161titaste \u017elezde u slede\u0107im slu\u010dajevima:<\/strong><\/h4><ul data-start=\"242\" data-end=\"489\"><li data-start=\"242\" data-end=\"340\"><p data-start=\"244\" data-end=\"340\">Eliminacija preostalog zdravog tkiva \u0161titaste \u017elezde nakon operacije karcinoma \u0161titaste \u017elezde<\/p><\/li><li data-start=\"341\" data-end=\"420\"><p data-start=\"343\" data-end=\"420\">Uni\u0161tavanje mikroskopskih \u0107elija karcinoma koje mogu ostati nakon operacije<\/p><\/li><li data-start=\"421\" data-end=\"489\"><p data-start=\"423\" data-end=\"489\">Uklanjanje preostalog tumorski tkiva ili metastaza nakon operacije<\/p><\/li><\/ul><p data-start=\"491\" data-end=\"659\">Ova terapija uklju\u010duje primenu supstance koja se naziva radioaktivni jod. Radioaktivni jod se apsorbuje od strane \u0107elija \u0161titaste \u017elezde i dovodi do njihovog uni\u0161tenja.<\/p><p data-start=\"661\" data-end=\"836\">Terapija radioaktivnim jodom je efikasan metod u le\u010denju diferenciranog karcinoma \u0161titaste \u017elezde. Mo\u017ee produ\u017eiti \u017eivotni vek pacijenata i pobolj\u0161ati kvalitet njihovog \u017eivota.<\/p><h4 data-start=\"843\" data-end=\"914\"><strong data-start=\"847\" data-end=\"914\">Terapija radioaktivnim jodom: Prvi primer teranosti\u010dkih primena<\/strong><\/h4><p data-start=\"916\" data-end=\"1321\"><strong data-start=\"916\" data-end=\"931\">Teranostika<\/strong> je novo i brzo rastu\u0107e polje u medicini. Radi se o pristupu u kojem se tumori i metastaze identifikovani putem snimanja uz pomo\u0107 agensa specifi\u010dnog za tumor tako\u0111e mogu le\u010diti drugim specifi\u010dnim agensom, \u010dija se ta\u010dna destinacija, rasprostranjenost i efekat na obolelo tkivo ve\u0107 poznaju. Ovaj pristup olak\u0161ava prelazak sa tradicionalne medicine na savremene personalizovane metode le\u010denja.<\/p><p data-start=\"1323\" data-end=\"1436\">Kod diferenciranog karcinoma \u0161titaste \u017elezde, teranosti\u010dke primene predstavljaju najraniji i najpoznatiji primer:<\/p><ul data-start=\"1438\" data-end=\"1719\"><li data-start=\"1438\" data-end=\"1600\"><p data-start=\"1440\" data-end=\"1600\"><strong data-start=\"1440\" data-end=\"1463\">Dijagnosti\u010dka svrha<\/strong> se ostvaruje snimanjem tumorskog tkiva visokom senzitivno\u0161\u0107u i specifi\u010dno\u0161\u0107u koriste\u0107i nisko-dozni radioaktivni jod (I-131 ili I-123).<\/p><\/li><li data-start=\"1601\" data-end=\"1719\"><p data-start=\"1603\" data-end=\"1719\"><strong data-start=\"1603\" data-end=\"1623\">Terapijska svrha<\/strong> se ostvaruje ciljanom terapijom tog istog tkiva pomo\u0107u visokodoznog radioaktivnog joda (I-131).<\/p><\/li><\/ul><hr data-start=\"1721\" data-end=\"1724\" \/><h4 data-start=\"1726\" data-end=\"1780\"><strong data-start=\"1730\" data-end=\"1780\">Kako funkcioni\u0161e terapija radioaktivnim jodom?<\/strong><\/h4><p data-start=\"1782\" data-end=\"2063\">Terapija radioaktivnim jodom je metoda koja se koristi za uni\u0161tavanje svih \u0107elija \u0161titaste \u017elezde, uklju\u010duju\u0107i i \u0107elije karcinoma. Radioaktivni jod se apsorbuje i skladi\u0161ti u \u0107elijama \u0161titaste \u017elezde na isti na\u010din kao i obi\u010dan jod. On o\u0161te\u0107uje \u0107elije i uzrokuje njihovo odumiranje.<\/p><p data-start=\"2065\" data-end=\"2273\">Ova terapija se koristi nakon operacije karcinoma \u0161titaste \u017elezde kako bi se spre\u010dilo ponovno javljanje bolesti. Tako\u0111e se koristi kod pacijenata \u010diji karcinom \u0161titaste \u017elezde ne reaguje na terapiju lekovima.<\/p><h3 data-start=\"2280\" data-end=\"2336\"><strong data-start=\"2284\" data-end=\"2336\">Kako se primenjuje terapija radioaktivnim jodom?<\/strong><\/h3><p data-start=\"2338\" data-end=\"2554\">Terapija radioaktivnim jodom se obi\u010dno sprovodi ambulantno u bolnici. Pre tretmana, nivo hormona \u0161titaste \u017elezde kod pacijenta se smanjuje kako bi se pove\u0107ala apsorpcija radioaktivnog joda u \u0107elijama \u0161titaste \u017elezde.<\/p><p data-start=\"2556\" data-end=\"2784\">Radioaktivni jod se daje oralno u obliku tableta ili intravenskom injekcijom. Nakon tretmana, pacijent ostaje na posmatranju u bolnici 24 sata. Tokom ovog perioda procenjuje se potencijalno zra\u010denje koje pacijent mo\u017ee emitovati.<\/p><h4 data-start=\"2791\" data-end=\"2837\"><strong data-start=\"2795\" data-end=\"2837\">Prednosti terapije radioaktivnim jodom<\/strong><\/h4><p data-start=\"2839\" data-end=\"3010\">Terapija radioaktivnim jodom je veoma efikasna u prevenciji recidiva karcinoma \u0161titaste \u017elezde. Mo\u017ee biti korisna i kod pacijenata kod kojih karcinom ne reaguje na lekove.<\/p><h4 data-start=\"3017\" data-end=\"3060\"><strong data-start=\"3021\" data-end=\"3060\">Ishodi terapije radioaktivnim jodom<\/strong><\/h4><p data-start=\"3062\" data-end=\"3288\">Ishodi ove terapije mogu varirati u zavisnosti od stadijuma bolesti i starosti pacijenta. Uop\u0161teno, terapija radioaktivnim jodom produ\u017eava \u017eivotni vek pacijenata sa karcinomom \u0161titaste \u017elezde i pobolj\u0161ava stope pre\u017eivljavanja.<\/p><h4 data-start=\"3295\" data-end=\"3351\"><strong data-start=\"3299\" data-end=\"3351\">Ko su kandidati za terapiju radioaktivnim jodom?<\/strong><\/h4><p data-start=\"3353\" data-end=\"3555\">Radioaktivni jod (I-131), poznat i kao radiojod, koristi se za le\u010denje osoba sa diferenciranim karcinomom \u0161titaste \u017elezde. Posebno se preporu\u010duje nakon totalne ili skoro totalne tireoidektomije u cilju:<\/p><ul data-start=\"3557\" data-end=\"3764\"><li data-start=\"3557\" data-end=\"3629\"><p data-start=\"3559\" data-end=\"3629\">Eliminacije ostataka normalnog tkiva \u0161titaste \u017elezde nakon operacije<\/p><\/li><li data-start=\"3630\" data-end=\"3697\"><p data-start=\"3632\" data-end=\"3697\">Adjuvantnog le\u010denja mikroskopskih subklini\u010dkih ostataka bolesti<\/p><\/li><li data-start=\"3698\" data-end=\"3764\"><p data-start=\"3700\" data-end=\"3764\">Le\u010denja makroskopskih ostataka, recidiva ili metastatske bolesti<\/p><\/li><\/ul><h4 data-start=\"3771\" data-end=\"3822\"><strong data-start=\"3775\" data-end=\"3822\">Postoperativna ablacija radioaktivnim jodom<\/strong><\/h4><p data-start=\"3824\" data-end=\"4344\">Ablacija radioaktivnim jodom se sprovodi nekoliko nedelja nakon operacije kako bi se uni\u0161tile preostale \u0107elije karcinoma ili zdrave \u0107elije \u0161titaste \u017elezde. Ova procedura ima za cilj i eliminaciju \u0107elija raka koje su se mo\u017eda pro\u0161irile na druge delove tela. Eliminacija ostataka zdravog tkiva \u0161titaste \u017elezde tako\u0111e olak\u0161ava pra\u0107enje eventualnog povratka bolesti. Pored toga, ablacija radioaktivnim jodom je povezana sa boljim stopama pre\u017eivljavanja kod pacijenata kod kojih se rak pro\u0161irio na vrat ili druge delove tela.<\/p><h4 data-start=\"4351\" data-end=\"4421\"><strong data-start=\"4355\" data-end=\"4421\">Preporuke za postoperativnu ablaciju radioaktivnim jodom (RAI)<\/strong><\/h4><p data-start=\"4423\" data-end=\"4604\">Prema klasifikaciji rizika Ameri\u010dkog udru\u017eenja za \u0161titastu \u017elezdu (ATA) i AJCC\/TNM sistemu stadijuma bolesti, savremene preporuke za primenu RAI terapije nakon operacije su slede\u0107e:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96268b1 elementor-widget elementor-widget-image\" data-id=\"96268b1\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"706\" src=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Snapinsta.app_468179357_18139926472361849_4707130066709828061_n_1080-kopya-1024x706.jpg\" class=\"attachment-large size-large wp-image-22268\" alt=\"\" srcset=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Snapinsta.app_468179357_18139926472361849_4707130066709828061_n_1080-kopya-1024x706.jpg 1024w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Snapinsta.app_468179357_18139926472361849_4707130066709828061_n_1080-kopya-300x207.jpg 300w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Snapinsta.app_468179357_18139926472361849_4707130066709828061_n_1080-kopya-768x530.jpg 768w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Snapinsta.app_468179357_18139926472361849_4707130066709828061_n_1080-kopya-1536x1059.jpg 1536w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Snapinsta.app_468179357_18139926472361849_4707130066709828061_n_1080-kopya.jpg 1566w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-54743f0 elementor-widget-tablet__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"54743f0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-24\" class=\"tablepress tablepress-id-24\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">ATA Risk Stratification<\/th><th class=\"column-2\">Definition<\/th><th class=\"column-3\">RAI Ablation Indication<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">ATA Low Risk<br \/>\n<br \/>\nT1a<br \/>\nN0, Nx<br \/>\nM0, Mx<br \/>\n<\/td><td class=\"column-2\">Tumor size \u22641 cm (single focus or multifocal)<\/td><td class=\"column-3\">None<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">ATA Low Risk<br \/>\n<br \/>\nT1b, T2<br \/>\nN0, Nx<br \/>\nM0, Mx<\/td><td class=\"column-2\">Tumor size >1\u20134 cm<\/td><td class=\"column-3\">May be considered. Not routine, but for patients with aggressive histology or vascular invasion<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">ATA Low to Intermediate Risk<br \/>\n<br \/>\nT3<br \/>\nN0, Nx<br \/>\nM0, Mx<\/td><td class=\"column-2\">Tumor size >4 cm<\/td><td class=\"column-3\">Generally recommended<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">ATA Low to Intermediate Risk<br \/>\n<br \/>\nT3<br \/>\nN0, Nx<br \/>\nM0, Mx<\/td><td class=\"column-2\">Microscopic extrathyroidal extension, any tumor size<\/td><td class=\"column-3\">Generally recommended<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">ATA Low to Intermediate Risk<br \/>\n<br \/>\nT1-3<br \/>\nN1a<br \/>\nM0, Mx<\/td><td class=\"column-2\">Central cervical compartment lymph node metastasis<\/td><td class=\"column-3\">Generally recommended<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">ATA Low to Intermediate Risk<br \/>\n<br \/>\nT1-3<br \/>\nN1b<br \/>\nM0, Mx<\/td><td class=\"column-2\">Lateral cervical or mediastinal lymph node metastasis<\/td><td class=\"column-3\">Generally recommended<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">ATA High Risk<br \/>\n<br \/>\nT4<br \/>\nAny N<br \/>\nAny M<\/td><td class=\"column-2\">Extensive extrathyroidal extension, any tumor size<\/td><td class=\"column-3\">Yes<\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">ATA High Risk<br \/>\n<br \/>\nM1<br \/>\nAny T<br \/>\nAny N<\/td><td class=\"column-2\">Distant metastases<\/td><td class=\"column-3\">Yes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-24 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d1a559f elementor-widget elementor-widget-heading\" data-id=\"d1a559f\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Sistem klasifikacije rizika Ameri\u010dkog udru\u017eenja za \u0161titastu \u017elezdu (ATA)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9c169d7 elementor-widget elementor-widget-text-editor\" data-id=\"9c169d7\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-17\" class=\"tablepress tablepress-id-17\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Risk Group<\/th><th class=\"column-2\">Metastases<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">No local or distant metastasis.<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">Complete removal of macroscopic tumor.<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">No tumor invasion to surrounding tissues and structures.<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">No aggressive tumor histology (e.g., tall cell variant, hobnail variant, columnar cell carcinoma).<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">If RA\u0130 is given, no uptake outside the thyroid bed in post-treatment scanning.<br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">No vascular invasion.<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">Clinically N0 or \u22645 pathological N1 micrometastases (largest diameter <0.2cm).<\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">Intrathyroidal encapsulated follicular variant papillary thyroid cancer.<\/td>\n<\/tr>\n<tr class=\"row-10 even\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">Intrathyroidal, well-differentiated follicular thyroid cancer with capsular invasion and minimal vascular invasion (<4 foci), without extensive vascular invasion.<\/td>\n<\/tr>\n<tr class=\"row-11 odd\">\n\t<td class=\"column-1\">Low Risk<\/td><td class=\"column-2\">Intrathyroidal papillary microcarcinoma, solitary or multifocal, with V600E BRAF mutation (if known).<\/td>\n<\/tr>\n<tr class=\"row-12 even\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Microscopic tumor invasion into perithyroidal soft tissues.<\/td>\n<\/tr>\n<tr class=\"row-13 odd\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Vascular invasion present in papillary thyroid carcinoma (PTC)<\/td>\n<\/tr>\n<tr class=\"row-14 even\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Uptake outside the thyroid bed in post-treatment whole-body iodine scan, localized in the neck.<\/td>\n<\/tr>\n<tr class=\"row-15 odd\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Aggressive tumor histology (e.g., tall cell variant, hobnail variant, columnar cell carcinoma)<\/td>\n<\/tr>\n<tr class=\"row-16 even\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Clinically N1 or >5 pathological N1 nodes with the largest diameter <3cm.<\/td>\n<\/tr>\n<tr class=\"row-17 odd\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Intrathyroidal papillary thyroid cancer, primary tumor size 1\u20134cm, with V600E BRAF mutation (if known).<\/td>\n<\/tr>\n<tr class=\"row-18 even\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Multifocal papillary microcarcinoma with extrathyroidal extension and V600E BRAF mutation (if known).<\/td>\n<\/tr>\n<tr class=\"row-19 odd\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Macroscopic tumor invasion into perithyroidal soft tissues (extensive extrathyroidal extension).<\/td>\n<\/tr>\n<tr class=\"row-20 even\">\n\t<td class=\"column-1\">Intermediate Risk<\/td><td class=\"column-2\">Incomplete tumor resection.<\/td>\n<\/tr>\n<tr class=\"row-21 odd\">\n\t<td class=\"column-1\">High Risk<\/td><td class=\"column-2\">Distant metastasis.<\/td>\n<\/tr>\n<tr class=\"row-22 even\">\n\t<td class=\"column-1\">High Risk<\/td><td class=\"column-2\">Postoperative high serum Tg level suggesting distant metastasis.<\/td>\n<\/tr>\n<tr class=\"row-23 odd\">\n\t<td class=\"column-1\">High Risk<\/td><td class=\"column-2\">Pathological N1 metastatic lymph node with the largest diameter >3cm.<\/td>\n<\/tr>\n<tr class=\"row-24 even\">\n\t<td class=\"column-1\">High Risk<\/td><td class=\"column-2\">Follicular thyroid cancer with extensive vascular invasion (>4 foci).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-17 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8ab03f4 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"8ab03f4\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Le\u010denje recidivnog ili rezidualnog diferenciranog karcinoma \u0161titaste \u017elezde radioaktivnim jodom<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e1710da elementor-widget elementor-widget-text-editor\" data-id=\"e1710da\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"flex-shrink-0 flex flex-col relative items-end\"><div class=\"pt-0\"><div class=\"gizmo-bot-avatar flex h-8 w-8 items-center justify-center overflow-hidden rounded-full\"><div class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\">Ako je tumorsko tkivo u obliku koji se mo\u017ee ukloniti hirur\u0161kim putem, hirur\u0161ka intervencija je obi\u010dno prvi izbor. Terapija radioaktivnim jodom mo\u017ee se primeniti samostalno ili u kombinaciji sa hirurgijom. Ako tumorsko \u017eari\u0161te ne pokazuje zna\u010dajno preuzimanje na scintigrafiji sa radioaktivnim jodom, ali se detektuje drugim metodama snimanja kao \u0161to su MRI ili 18F-FDG-PET, treba posumnjati na diferencirani karcinom \u0161titaste \u017elezde koji je refraktoran na radioaktivni jod.<\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1e540ec elementor-widget elementor-widget-heading\" data-id=\"1e540ec\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Le\u010denje diferenciranog karcinoma \u0161titaste \u017elezde refrakternog na radioaktivni jod<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b23c196 elementor-widget elementor-widget-text-editor\" data-id=\"b23c196\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><p data-start=\"59\" data-end=\"235\">Metastatsko tkivo uop\u0161te ne apsorbuje radioaktivni jod (nema \u0161irenja van regije \u0161titaste \u017elezde uo\u010denog na scintigrafiji celog tela prilikom postavljanja inicijalne dijagnoze).<\/p><p data-start=\"237\" data-end=\"398\">Uprkos prethodnim znacima osetljivosti na radioaktivni jod, tumorsko tkivo gubi sposobnost apsorpcije radioaktivnog joda (u odsustvu trajne kontaminacije jodom).<\/p><p data-start=\"400\" data-end=\"478\">Neke lezije mogu apsorbovati radioaktivni jod, dok druge nemaju tu sposobnost.<\/p><p data-start=\"480\" data-end=\"557\">Metastatska bolest napreduje uprkos zna\u010dajnom preuzimanju radioaktivnog joda.<\/p><p data-start=\"559\" data-end=\"945\">Kod pacijenata sa diferenciranim karcinomom \u0161titaste \u017elezde koji je rezistentan na radioaktivni jod, mogu se primeniti lokalni tretmani kao \u0161to su termalna ablacija ili stereotakti\u010dka radioterapija. Pored toga, inhibitori kinaze mogu se koristiti u sistemskoj terapiji. Citotoksi\u010dne hemoterapije se mogu razmatrati u slu\u010dajevima kada druge metode ne obezbe\u0111uju zadovoljavaju\u0107u kontrolu.<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ed7d989 elementor-widget elementor-widget-heading\" data-id=\"ed7d989\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Da li je terapija radioaktivnim jodom bezbedna?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c55239f elementor-widget elementor-widget-text-editor\" data-id=\"c55239f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Terapija radioaktivnim jodom ne mo\u017ee se primenjivati tokom trudno\u0107e. Majke koje doje treba da prekinu dojenje. Metod terapije radioaktivnim jodom mo\u017ee se primeniti kod pacijenata na hemodijalizi. Mogu\u0107e je primeniti terapiju radioaktivnim jodom kod pacijenata sa alergijom na jod. Kod pacijenata sa bubre\u017enom insuficijencijom, doza rhTSH mo\u017ee se smanjiti za 50% ili vi\u0161e. \u017denama i mu\u0161karcima se savetuje da koriste efikasne metode kontracepcije i izbegavaju trudno\u0107u najmanje 6 meseci nakon le\u010denja.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-145f1f4 elementor-widget elementor-widget-heading\" data-id=\"145f1f4\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Mogu\u0107i ne\u017eeljeni efekti terapije radioaktivnim jodom<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a7872bb elementor-widget elementor-widget-text-editor\" data-id=\"a7872bb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-18\" class=\"tablepress tablepress-id-18\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Side Effect<\/th><th class=\"column-2\">Recommendation\/Explanation<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Burning sensation or sensitivity in the neck area\t<\/td><td class=\"column-2\">In ablation; related to the amount of residual thyroid tissue after surgery. Steroids or NSAIDs can be used.<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Oral mucositis and small painful ulcers<\/td><td class=\"column-2\">For 4-7 days, gently brush the entire oral mucosa with a soft toothbrush every 3-4 hours while awake. This condition can often be prevented. Additionally, for the first 4 days after treatment, application every 3 hours at night can be included.<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Nausea (and rarely vomiting)<\/td><td class=\"column-2\">-5-HT3 antagonists (e.g., ondansetron, granisetron, every 8-12 hours) \\n -Dexamethasone (every 8-12 hours)<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Swelling and sensitivity in salivary glands<\/td><td class=\"column-2\">-High-level hydration, approximately 2.5-3 liters of fluid (excluding milk) daily for 1 week. \\n -Stimulate salivary flow with sialagogues (e.g., sugar-free gum\/candy, pilocarpine, and ascorbic acid). Start 2 hours after RAI application, continuing every waking hour for 4 days and every 3 hours for 4 nights after treatment. \\n -Dexamethasone (every 8-12 hours) \\n -Amifostin<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">Reduction or change in taste sensation<\/td><td class=\"column-2\">Generally temporary<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">Decrease in tear production<\/td><td class=\"column-2\">High doses of RAI (150-200 mCi) may cause this. However, this is not expected in patients with normal blood counts and normal renal function before treatment.<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">Temporary decrease in white blood cell and platelet counts<\/td><td class=\"column-2\">High doses of RAI (150-200 mCi) may cause this. However, this is not expected in patients with normal blood counts and normal renal function before treatment.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-18 from cache --><\/p><p>\n<table id=\"tablepress-19\" class=\"tablepress tablepress-id-19\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Late Side Effects<\/th><th class=\"column-2\">Recommendation\/Explanation<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Male fertility<\/td><td class=\"column-2\">Increased FSH levels and decreased spermatogenesis-related temporary infertility can be seen with high RAI treatment doses. In cases where the cumulative dose from repeated treatments exceeds 200-300 mCi, permanent infertility may develop. Freezing sperm before high-dose RAI treatment can be considered. Radiation exposure to the testes can be reduced by frequent urination.<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Female fertility<\/td><td class=\"column-2\">No significant risk of impaired fertility or increased risk of miscarriage has been observed with RAI treatment.<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Dry mouth (xerostomia)<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Taste changes (dysgeusia)<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">Salivary gland stone (sialolithiasis)<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">Tooth decay<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">Dry eyes (xerophthalmia) or epiphora<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">Secondary malignancy development<\/td><td class=\"column-2\">This is a very rare condition (<1%) seen after high-dose RAI application. Reported cases generally involve patients who have received multiple RAI treatments. This possibility should be considered alongside the risks posed by thyroid cancer.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-19 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cbc4ec5 elementor-widget elementor-widget-heading\" data-id=\"cbc4ec5\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Priprema pre terapije radioaktivnim jodom<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f1569a3 elementor-widget elementor-widget-text-editor\" data-id=\"f1569a3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"0\" data-end=\"197\">Terapija radioaktivnim jodom je efikasna metoda koja se koristi u le\u010denju karcinoma \u0161titaste \u017elezde. Da bi se pove\u0107ala efikasnost ove terapije, pacijenti moraju biti adekvatno pripremljeni unapred.<\/p><p data-start=\"199\" data-end=\"221\"><strong data-start=\"199\" data-end=\"221\">Priprema pacijenta<\/strong><\/p><p data-start=\"223\" data-end=\"483\">Pre terapije radioaktivnim jodom, sprovodi se fizi\u010dki pregled uz analizu medicinske istorije povezane sa \u0161titastom \u017elezdom, hirur\u0161kih\/patolo\u0161kih izve\u0161taja, prethodnih snimanja i prethodnih doza terapije radioaktivnim jodom. Tako\u0111e se rade slede\u0107e analize krvi:<\/p><ul data-start=\"485\" data-end=\"773\"><li data-start=\"485\" data-end=\"542\"><p data-start=\"487\" data-end=\"542\">Testovi funkcije \u0161titaste \u017elezde (npr. TSH, fT3, fT4)<\/p><\/li><li data-start=\"543\" data-end=\"565\"><p data-start=\"545\" data-end=\"565\">Tireoglobulin (Tg)<\/p><\/li><li data-start=\"566\" data-end=\"577\"><p data-start=\"568\" data-end=\"577\">Anti-Tg<\/p><\/li><li data-start=\"578\" data-end=\"608\"><p data-start=\"580\" data-end=\"608\">Serum kalcijum, kalcitonin<\/p><\/li><li data-start=\"609\" data-end=\"634\"><p data-start=\"611\" data-end=\"634\">Kompletna krvna slika<\/p><\/li><li data-start=\"635\" data-end=\"677\"><p data-start=\"637\" data-end=\"677\">Bubre\u017eni profil (npr. urea, kreatinin)<\/p><\/li><li data-start=\"678\" data-end=\"773\"><p data-start=\"680\" data-end=\"773\">Beta-hCG: Ovaj test se radi kod svih \u017eena reproduktivnog uzrasta radi isklju\u010divanja trudno\u0107e.<\/p><\/li><\/ul><p data-start=\"775\" data-end=\"818\"><strong data-start=\"775\" data-end=\"818\">Prekid upotrebe hormona \u0161titaste \u017elezde<\/strong><\/p><p data-start=\"820\" data-end=\"1091\">Postizanje visokog nivoa TSH u krvi je klju\u010dno za maksimizaciju efikasnosti terapije radioaktivnim jodom. TSH pove\u0107ava preuzimanje radioaktivnog joda i u zdravom tkivu i u \u0107elijama karcinoma \u0161titaste \u017elezde. Postoji nekoliko na\u010dina za pove\u0107anje ovog hormona pre terapije:<\/p><p data-start=\"1093\" data-end=\"1546\"><strong data-start=\"1093\" data-end=\"1137\">Prekid upotrebe hormona \u0161titaste \u017elezde:<\/strong><br data-start=\"1137\" data-end=\"1140\" \/>Ako se planira prekid upotrebe hormona \u0161titaste \u017elezde pre ablacije\/terapije radioaktivnim jodom, LT4 hormon (Levotiroksin, Tefor, Eutiroks, Bitiron) treba prekinuti najmanje 4 nedelje ranije, a LT3 hormon (Liotironin) najmanje 2 nedelje ranije. Pacijenti koji koriste LT4 mogu koristiti LT3 tokom prve dve nedelje prekida. Ciljani nivo TSH je &gt;30 mIU\/L i TSH treba izmeriti pre primene radioaktivnog joda.<\/p><p data-start=\"1548\" data-end=\"1989\"><strong data-start=\"1548\" data-end=\"1588\">Upotreba rekombinantnog TSH (rhTSH):<\/strong><br data-start=\"1588\" data-end=\"1591\" \/>Alternativa prekidu hormona je primena rekombinantnog TSH (Thyrogen), koji se daje intramuskularno u gluteus u dve doze sa razmakom od 24 sata. Radioaktivni jod se daje oralno 24 sata nakon poslednje injekcije. Dijagnosti\u010dko merenje tireoglobulina (Tg) treba obaviti 72 sata nakon poslednje injekcije rhTSH. Kod pacijenata sa bubre\u017enom insuficijencijom, doza rhTSH mo\u017ee se smanjiti za 50% ili vi\u0161e.<\/p><p data-start=\"1991\" data-end=\"2007\"><strong data-start=\"1991\" data-end=\"2007\">Hrana i pi\u0107e<\/strong><\/p><p data-start=\"2009\" data-end=\"2168\">Konzumacija hrane i lekova koji sadr\u017ee jod treba biti ograni\u010dena pre i posle terapije radioaktivnim jodom, jer mogu smanjiti efikasnost tretmana. To uklju\u010duje:<\/p><ul data-start=\"2170\" data-end=\"2406\"><li data-start=\"2170\" data-end=\"2231\"><p data-start=\"2172\" data-end=\"2231\">Morski plodovi (npr. riba, \u0161kampi, ostrige, \u0161koljke itd.)<\/p><\/li><li data-start=\"2232\" data-end=\"2247\"><p data-start=\"2234\" data-end=\"2247\">Jodirana so<\/p><\/li><li data-start=\"2248\" data-end=\"2280\"><p data-start=\"2250\" data-end=\"2280\">Jodirani vitamini i minerali<\/p><\/li><li data-start=\"2281\" data-end=\"2406\"><p data-start=\"2283\" data-end=\"2406\">Odre\u0111eni lekovi (npr. amiodaron, amoksicilin, amoksicilin-klavulanat, hloramfenikol, metamizol, jodirani kontrastni agensi)<\/p><\/li><\/ul><p data-start=\"2408\" data-end=\"2426\"><strong data-start=\"2408\" data-end=\"2426\">Nakon tretmana<\/strong><\/p><p data-start=\"2428\" data-end=\"2640\">Nakon terapije radioaktivnim jodom, pacijent mora ostati u izolaciji nekoliko dana kako bi se spre\u010dilo izlaganje drugih osoba zra\u010denju. Tokom ovog perioda potrebno je pridr\u017eavati se slede\u0107ih mera predostro\u017enosti:<\/p><ul data-start=\"2642\" data-end=\"2859\"><li data-start=\"2642\" data-end=\"2689\"><p data-start=\"2644\" data-end=\"2689\">Izbegavati blizak kontakt sa drugim osobama<\/p><\/li><li data-start=\"2690\" data-end=\"2758\"><p data-start=\"2692\" data-end=\"2758\">Temeljno pranje ruku i genitalne regije nakon kori\u0161\u0107enja toaleta<\/p><\/li><li data-start=\"2759\" data-end=\"2808\"><p data-start=\"2761\" data-end=\"2808\">Ne deliti toalet i kupatilo sa drugim osobama<\/p><\/li><li data-start=\"2809\" data-end=\"2859\"><p data-start=\"2811\" data-end=\"2859\">Izbegavati blizak kontakt sa ku\u0107nim ljubimcima<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-032801c elementor-widget elementor-widget-heading\" data-id=\"032801c\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Plan ishrane sa niskim unosom joda<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-be7894e elementor-widget elementor-widget-text-editor\" data-id=\"be7894e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Pre po\u010detka terapije radioaktivnim jodom, potrebno je pridr\u017eavati se va\u017enog dijetetskog re\u017eima. Ova dijeta po\u010dinje 2 nedelje pre terapije i nastavlja se 1\u20132 dana nakon tretmana. Svrha ove dijete sa niskim unosom joda je da pobolj\u0161a pozitivne efekte terapije radioaktivnim jodom na pacijentovo telo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-66877be elementor-widget elementor-widget-heading\" data-id=\"66877be\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Lekovi koji spre\u010davaju preuzimanje radioaktivnog joda<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0118d35 elementor-widget elementor-widget-text-editor\" data-id=\"0118d35\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-20\" class=\"tablepress tablepress-id-20\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Medications<\/th><th class=\"column-2\">Recommended Discontinuation Period<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Thionamide drugs (e.g., propylthiouracil, methimazole, carbimazole)<\/td><td class=\"column-2\">3 days<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Iodine-containing multivitamins<\/td><td class=\"column-2\">7-10 days<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Natural\/synthetic thyroid hormones, triiodothyronine (LT3, Tiromel)<\/td><td class=\"column-2\">10-14 days<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Natural\/synthetic thyroid hormones, thyroxine (LT4, Levothyroxine, Tefor, Euthyrox, Bitiron)<\/td><td class=\"column-2\">3-4 weeks<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">Kelp, agar, carrageenan, Lugol&#8217;s solution<\/td><td class=\"column-2\">2-3 weeks, depending on iodine content<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">Potassium iodide saturated solution<\/td><td class=\"column-2\">2-3 weeks<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">Topical iodine (e.g., surgical skin preparation)<\/td><td class=\"column-2\">2-3 weeks<\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">Intravenous radiographic contrast agent, water-soluble<\/td><td class=\"column-2\">6-8 weeks<\/td>\n<\/tr>\n<tr class=\"row-10 even\">\n\t<td class=\"column-1\">Intravenous radiographic contrast agent, fat-soluble<\/td><td class=\"column-2\">1-6 months<\/td>\n<\/tr>\n<tr class=\"row-11 odd\">\n\t<td class=\"column-1\">Amiodarone<\/td><td class=\"column-2\">3-6 months or longer<\/td>\n<\/tr>\n<tr class=\"row-12 even\">\n\t<td class=\"column-1\">Hair dye<\/td><td class=\"column-2\">8 weeks<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-20 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d09e73c elementor-widget elementor-widget-text-editor\" data-id=\"d09e73c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Namirnice koje nisu dozvoljene jer sadr\u017ee visoke koli\u010dine joda<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4757a7c elementor-widget elementor-widget-text-editor\" data-id=\"4757a7c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-21\" class=\"tablepress tablepress-id-21\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Source<\/th><th class=\"column-2\">Example\/Description<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Iodized salt<\/td><td class=\"column-2\">Milk, yogurt, cheese, ice cream<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Egg yolk<\/td><td class=\"column-2\">Not egg white or egg substitutes<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Seafood<\/td><td class=\"column-2\">Shellfish and fish, excluding tuna<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Turkey and liver<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">Seaweed and seaweed products<\/td><td class=\"column-2\">Carrageenan and alginate<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">Milk chocolate<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">Iodine-containing multivitamins<\/td><td class=\"column-2\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">Red food coloring (E127, erythrosine) containing products<\/td><td class=\"column-2\">(e.g., medicine dye, carbonated drinks)<\/td>\n<\/tr>\n<tr class=\"row-10 even\">\n\t<td class=\"column-1\">Grains<\/td><td class=\"column-2\">Only small portions at each meal (e.g., one-quarter of a plate).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-21 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cd09ffa elementor-widget elementor-widget-text-editor\" data-id=\"cd09ffa\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Dozvoljene namirnice<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-33517a6 elementor-widget elementor-widget-text-editor\" data-id=\"33517a6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-22\" class=\"tablepress tablepress-id-22\">\n<tbody class=\"row-hover\">\n<tr class=\"row-1 odd\">\n\t<td class=\"column-1\">Fresh fruits and vegetables<\/td>\n<\/tr>\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Unsalted peanuts\/nuts and peanut\/nut butter<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Egg whites<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Fresh meat<\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Grains\/cereal products that are low in iodine (limited to 4 servings per day)<\/td>\n<\/tr>\n<tr class=\"row-6 even\">\n\t<td class=\"column-1\">Pasta, low in iodine<\/td>\n<\/tr>\n<tr class=\"row-7 odd\">\n\t<td class=\"column-1\">Sugar<\/td>\n<\/tr>\n<tr class=\"row-8 even\">\n\t<td class=\"column-1\">Jelly<\/td>\n<\/tr>\n<tr class=\"row-9 odd\">\n\t<td class=\"column-1\">Jam<\/td>\n<\/tr>\n<tr class=\"row-10 even\">\n\t<td class=\"column-1\">Honey<\/td>\n<\/tr>\n<tr class=\"row-11 odd\">\n\t<td class=\"column-1\">Black pepper<\/td>\n<\/tr>\n<tr class=\"row-12 even\">\n\t<td class=\"column-1\">Fresh or dried herbs and spices<\/td>\n<\/tr>\n<tr class=\"row-13 odd\">\n\t<td class=\"column-1\">All vegetable oils (including soybean oil)<\/td>\n<\/tr>\n<tr class=\"row-14 even\">\n\t<td class=\"column-1\">Soda (not containing Red Dye (E127))<\/td>\n<\/tr>\n<tr class=\"row-15 odd\">\n\t<td class=\"column-1\">Cola, diet cola<\/td>\n<\/tr>\n<tr class=\"row-16 even\">\n\t<td class=\"column-1\">Coffee (not instant)<\/td>\n<\/tr>\n<tr class=\"row-17 odd\">\n\t<td class=\"column-1\">Tea (not instant)<\/td>\n<\/tr>\n<tr class=\"row-18 even\">\n\t<td class=\"column-1\">Lemonade<\/td>\n<\/tr>\n<tr class=\"row-19 odd\">\n\t<td class=\"column-1\">Fruit juices<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-22 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c79956f elementor-widget elementor-widget-image\" data-id=\"c79956f\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"579\" src=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Fresh-fruit-and-vegetables_Unsalted-peanuts_nuts-and-peanut_nut-butter_Egg-white_Fresh-meat_Cereals_-1024x579.jpeg\" class=\"attachment-large size-large wp-image-22274\" alt=\"\" srcset=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Fresh-fruit-and-vegetables_Unsalted-peanuts_nuts-and-peanut_nut-butter_Egg-white_Fresh-meat_Cereals_-1024x579.jpeg 1024w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Fresh-fruit-and-vegetables_Unsalted-peanuts_nuts-and-peanut_nut-butter_Egg-white_Fresh-meat_Cereals_-300x170.jpeg 300w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Fresh-fruit-and-vegetables_Unsalted-peanuts_nuts-and-peanut_nut-butter_Egg-white_Fresh-meat_Cereals_-768x434.jpeg 768w, https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/12\/Fresh-fruit-and-vegetables_Unsalted-peanuts_nuts-and-peanut_nut-butter_Egg-white_Fresh-meat_Cereals_.jpeg 1472w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-93d4e0d elementor-widget elementor-widget-heading\" data-id=\"93d4e0d\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\nKako se sprovodi terapija radioaktivnim jodom?<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0ef072c elementor-widget elementor-widget-text-editor\" data-id=\"0ef072c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"0\" data-end=\"166\">Pre primene radioaktivnog joda, unos hrane i vode treba potpuno obustaviti na 4\u20136 sati. Ovo ograni\u010denje treba da se nastavi jo\u0161 2 sata nakon unosa radioaktivnog joda.<\/p><p data-start=\"168\" data-end=\"277\">Ako se razmatra primena profilakti\u010dkih oralnih antiemetika, preporu\u010dljivo je da se daju pre po\u010detka terapije.<\/p><p data-start=\"279\" data-end=\"421\">Doza radioaktivnog joda planirana za le\u010denje je u te\u010dnom ili kapsuliranom obliku i uzima se oralno u posebno odre\u0111enoj prostoriji za terapiju.<\/p><p data-start=\"423\" data-end=\"551\">Trajanje hospitalizacije varira u zavisnosti od primenjene doze i merenja kod pacijenta. Obi\u010dno se kre\u0107e od 3 dana do 1 nedelje.<\/p><p data-start=\"553\" data-end=\"691\">U periodu od 3\u20137 dana nakon terapije, radi se scintigrafija celog tela radioaktivnim jodom\/SPECT\/CT u svrhu odre\u0111ivanja stadijuma bolesti.<\/p><p data-start=\"693\" data-end=\"805\" data-is-last-node=\"\" data-is-only-node=\"\">Pri izboru doze koja \u0107e se primeniti uzimaju se u obzir procene rizika od recidiva karcinoma ili smrtnog ishoda.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0f885bf elementor-widget elementor-widget-text-editor\" data-id=\"0f885bf\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Preporu\u010dene doze radioaktivnog joda za razli\u010dita klini\u010dka stanja<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0e1f86d elementor-widget elementor-widget-text-editor\" data-id=\"0e1f86d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\n<table id=\"tablepress-23\" class=\"tablepress tablepress-id-23\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Indication<\/th><th class=\"column-2\">Recommended RAI Dose<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\">Ablation of remnant tissue in the thyroid bed after surgery<\/td><td class=\"column-2\">1.11\u20133.7 MBq (30\u2013100 mCi)<\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\">Treatment of cervical\/mediastinal lymph node metastases<\/td><td class=\"column-2\">5.55\u20137.4 MBq (150\u2013200 mCi)<\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\">Patients with advanced local\/regional disease should undergo surgery first, followed by RAI or external radiation therapy if clinically indicated<\/td><td class=\"column-2\"><\/td>\n<\/tr>\n<tr class=\"row-5 odd\">\n\t<td class=\"column-1\">Treatment of distant metastases<\/td><td class=\"column-2\">\u22657.4 MBq (\u2265200 mCi)<br \/>\nLet me know if you need further adjustments!<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-23 from cache --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ffa2444 elementor-widget elementor-widget-text-editor\" data-id=\"ffa2444\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4 data-start=\"75\" data-end=\"106\"><strong data-start=\"79\" data-end=\"106\">Doze radioaktivnog joda<\/strong><\/h4><p data-start=\"108\" data-end=\"251\">Doze koje se koriste za terapiju radioaktivnim jodom variraju u zavisnosti od klini\u010dkog stanja pacijenta. Uop\u0161teno se preporu\u010duju slede\u0107e doze:<\/p><ul data-start=\"253\" data-end=\"504\"><li data-start=\"253\" data-end=\"339\"><p data-start=\"255\" data-end=\"339\">Za ablaciju preostalog tkiva \u0161titaste \u017elezde nakon operacije: <strong data-start=\"317\" data-end=\"337\">131I 100\u2013150 mCi<\/strong><\/p><\/li><li data-start=\"340\" data-end=\"430\"><p data-start=\"342\" data-end=\"430\">Za le\u010denje recidivnog ili metastatskog karcinoma \u0161titaste \u017elezde: <strong data-start=\"408\" data-end=\"428\">131I 300\u2013500 mCi<\/strong><\/p><\/li><li data-start=\"431\" data-end=\"504\"><p data-start=\"433\" data-end=\"504\">Za pacijente sa povi\u0161enim nivoima tireoglobulina: <strong data-start=\"483\" data-end=\"504\">131I 600\u20131000 mCi<\/strong><\/p><\/li><\/ul><h4 data-start=\"511\" data-end=\"535\"><strong data-start=\"515\" data-end=\"535\">Funkcija bubrega<\/strong><\/h4><p data-start=\"537\" data-end=\"801\">Za pacijente sa normalnom bubre\u017enom funkcijom preporu\u010duje se unos <strong data-start=\"603\" data-end=\"634\">2,5\u20133 litra te\u010dnosti dnevno<\/strong> (bez mleka) i \u010desto mokrenje tokom <strong data-start=\"670\" data-end=\"683\">1 nedelje<\/strong> nakon primene radioaktivnog joda. Ovo poma\u017ee da se minimizira doza zra\u010denja koju apsorbuju be\u0161ika i pljuva\u010dne \u017elezde.<\/p><h4 data-start=\"808\" data-end=\"832\"><strong data-start=\"812\" data-end=\"832\">Pra\u017enjenje creva<\/strong><\/h4><p data-start=\"834\" data-end=\"1015\">Neophodno je imati <strong data-start=\"853\" data-end=\"895\">najmanje jedno pra\u017enjenje creva dnevno<\/strong> kako bi se smanjila doza zra\u010denja koju apsorbuje debelo crevo. U slu\u010daju zatvora mogu se koristiti <strong data-start=\"995\" data-end=\"1014\">blagi laksativi<\/strong>.<\/p><h4 data-start=\"1022\" data-end=\"1059\"><strong data-start=\"1026\" data-end=\"1059\">Hospitalizacija zbog terapije<\/strong><\/h4><p data-start=\"1061\" data-end=\"1189\">Pacijenti koji primaju dozu radioaktivnog joda <strong data-start=\"1108\" data-end=\"1127\">vi\u0161u od 100 mCi<\/strong> le\u010de se u bolni\u010dkim uslovima radi <strong data-start=\"1162\" data-end=\"1188\">sigurnosti od zra\u010denja<\/strong>.<\/p><h4 data-start=\"1196\" data-end=\"1225\"><strong data-start=\"1200\" data-end=\"1225\">Kriterijumi za otpust<\/strong><\/h4><p data-start=\"1227\" data-end=\"1492\">Pacijenti koji primaju terapiju radioaktivnim jodom, bilo ambulantno ili stacionarno, mogu biti otpu\u0161teni iz bolnice <strong data-start=\"1344\" data-end=\"1423\">tek kada nivo zaostale radioaktivnosti u telu padne ispod granica za otpust<\/strong> propisanih od strane <strong data-start=\"1445\" data-end=\"1491\">Turske agencije za atomsku energiju (TAEK)<\/strong>.<\/p><h4 data-start=\"1499\" data-end=\"1520\"><strong data-start=\"1503\" data-end=\"1520\">Kontracepcija<\/strong><\/h4><p data-start=\"1522\" data-end=\"1690\">\u017dene i mu\u0161karci koji primaju terapiju radioaktivnim jodom moraju koristiti <strong data-start=\"1597\" data-end=\"1630\">efikasne metode kontracepcije<\/strong> i izbegavati trudno\u0107u najmanje <strong data-start=\"1662\" data-end=\"1689\">6 meseci nakon terapije<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-b9e26e7\" data-id=\"b9e26e7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-afd68e2 elementor-widget elementor-widget-sidebar\" data-id=\"afd68e2\" data-element_type=\"widget\" data-widget_type=\"sidebar.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"widget_text chw-widget\"><div class=\"textwidget custom-html-widget\">\t\t<div data-elementor-type=\"section\" data-elementor-id=\"22654\" class=\"elementor elementor-22654\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3a2a9f1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3a2a9f1\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-fd2e319\" data-id=\"fd2e319\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c12a220 elementor-position-left elementor-vertical-align-middle elementor-widget elementor-widget-image-box\" data-id=\"c12a220\" data-element_type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.neolife.com.tr\/sr\/skrining-raka\/\" tabindex=\"-1\"><img decoding=\"async\" width=\"65\" height=\"65\" src=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2025\/09\/66.png\" class=\"attachment-full size-full wp-image-29625\" alt=\"\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><p class=\"elementor-image-box-description\"><a href=\"https:\/\/www.neolife.com.tr\/sr\/skrining-raka\/\"> Skrining Raka\n  <\/a><\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-d46d5bd\" data-id=\"d46d5bd\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ef0373f elementor-position-left elementor-vertical-align-middle elementor-widget elementor-widget-image-box\" data-id=\"ef0373f\" data-element_type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.neolife.com.tr\/sr\/nasi-lekari\/\" tabindex=\"-1\"><img loading=\"lazy\" decoding=\"async\" width=\"65\" height=\"65\" src=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2025\/09\/indir.png\" class=\"attachment-full size-full wp-image-29632\" alt=\"\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><p class=\"elementor-image-box-description\"><a href=\"https:\/\/www.neolife.com.tr\/sr\/nasi-lekari\/\"> Upoznajte na\u0161e stru\u010dno osoblje\n<\/a><\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-a1c5e73\" data-id=\"a1c5e73\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b7b23ff elementor-position-left elementor-vertical-align-middle elementor-widget elementor-widget-image-box\" data-id=\"b7b23ff\" data-element_type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.neolife.com.tr\/sr\/neolife-kontrolni-centar\/\" tabindex=\"-1\"><img loading=\"lazy\" decoding=\"async\" width=\"65\" height=\"65\" src=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2025\/09\/indir-1.png\" class=\"attachment-full size-full wp-image-29639\" alt=\"\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><p class=\"elementor-image-box-description\"><a href=\"https:\/\/www.neolife.com.tr\/sr\/neolife-kontrolni-centar\/\"> Neolife Kontrolni Centar\n  <\/a><\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Terapija radioaktivnim jodom Terapija radioaktivnim jodom se preporu\u010duje pacijentima sa diferenciranim karcinomom \u0161titaste \u017elezde u slede\u0107im slu\u010dajevima: Eliminacija preostalog zdravog tkiva \u0161titaste \u017elezde nakon operacije karcinoma \u0161titaste \u017elezde Uni\u0161tavanje mikroskopskih \u0107elija karcinoma koje mogu ostati nakon operacije Uklanjanje preostalog tumorski tkiva ili metastaza nakon operacije Ova terapija uklju\u010duje primenu supstance koja se naziva radioaktivni jod. [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":22206,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-27564","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Terapija radioaktivnim jodom - Neolife T\u0131p Merkezi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/\" \/>\n<meta name=\"twitter:label1\" content=\"\u041f\u0440\u043e\u0446\u0435\u045a\u0435\u043d\u043e \u0432\u0440\u0435\u043c\u0435 \u0447\u0438\u0442\u0430\u045a\u0430\" \/>\n\t<meta name=\"twitter:data1\" content=\"19 \u043c\u0438\u043d\u0443\u0442\u0430\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/\",\"url\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/\",\"name\":\"Terapija radioaktivnim jodom - Neolife T\u0131p Merkezi\",\"isPartOf\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/01\/Siemens_Magnetom-Vida_MRI_system-kopya.jpg\",\"datePublished\":\"2025-07-21T16:43:48+00:00\",\"dateModified\":\"2025-07-21T17:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#breadcrumb\"},\"inLanguage\":\"sr-RS\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#primaryimage\",\"url\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/01\/Siemens_Magnetom-Vida_MRI_system-kopya.jpg\",\"contentUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/01\/Siemens_Magnetom-Vida_MRI_system-kopya.jpg\",\"width\":4500,\"height\":3000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana Sayfa\",\"item\":\"https:\/\/www.neolife.com.tr\/sr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Terapija radioaktivnim jodom\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neolife.com.tr\/#website\",\"url\":\"https:\/\/www.neolife.com.tr\/\",\"name\":\"Neolife T\u0131p Merkezi\",\"description\":\"T\u00fcrkiye&#039;de kanser tedavisi - kanser te\u015fhisi ve tedavisi\",\"publisher\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neolife.com.tr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sr-RS\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.neolife.com.tr\/#organization\",\"name\":\"Neolife T\u0131p Merkezi\",\"url\":\"https:\/\/www.neolife.com.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png\",\"contentUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png\",\"width\":348,\"height\":92,\"caption\":\"Neolife T\u0131p Merkezi\"},\"image\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NeoLifeIstanbul\/\",\"https:\/\/x.com\/NeoLifeIstanbul\",\"https:\/\/www.linkedin.com\/company\/neolife-oncology-center\/?originalSubdomain=tr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Terapija radioaktivnim jodom - Neolife T\u0131p Merkezi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/","twitter_misc":{"\u041f\u0440\u043e\u0446\u0435\u045a\u0435\u043d\u043e \u0432\u0440\u0435\u043c\u0435 \u0447\u0438\u0442\u0430\u045a\u0430":"19 \u043c\u0438\u043d\u0443\u0442\u0430"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/","url":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/","name":"Terapija radioaktivnim jodom - Neolife T\u0131p Merkezi","isPartOf":{"@id":"https:\/\/www.neolife.com.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#primaryimage"},"image":{"@id":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/01\/Siemens_Magnetom-Vida_MRI_system-kopya.jpg","datePublished":"2025-07-21T16:43:48+00:00","dateModified":"2025-07-21T17:01:41+00:00","breadcrumb":{"@id":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#breadcrumb"},"inLanguage":"sr-RS","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/"]}]},{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#primaryimage","url":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/01\/Siemens_Magnetom-Vida_MRI_system-kopya.jpg","contentUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2024\/01\/Siemens_Magnetom-Vida_MRI_system-kopya.jpg","width":4500,"height":3000},{"@type":"BreadcrumbList","@id":"https:\/\/www.neolife.com.tr\/sr\/terapija-radioaktivnim-jodom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana Sayfa","item":"https:\/\/www.neolife.com.tr\/sr\/"},{"@type":"ListItem","position":2,"name":"Terapija radioaktivnim jodom"}]},{"@type":"WebSite","@id":"https:\/\/www.neolife.com.tr\/#website","url":"https:\/\/www.neolife.com.tr\/","name":"Neolife T\u0131p Merkezi","description":"T\u00fcrkiye&#039;de kanser tedavisi - kanser te\u015fhisi ve tedavisi","publisher":{"@id":"https:\/\/www.neolife.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neolife.com.tr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sr-RS"},{"@type":"Organization","@id":"https:\/\/www.neolife.com.tr\/#organization","name":"Neolife T\u0131p Merkezi","url":"https:\/\/www.neolife.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png","contentUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png","width":348,"height":92,"caption":"Neolife T\u0131p Merkezi"},"image":{"@id":"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NeoLifeIstanbul\/","https:\/\/x.com\/NeoLifeIstanbul","https:\/\/www.linkedin.com\/company\/neolife-oncology-center\/?originalSubdomain=tr"]}]}},"_links":{"self":[{"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/pages\/27564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/comments?post=27564"}],"version-history":[{"count":4,"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/pages\/27564\/revisions"}],"predecessor-version":[{"id":27571,"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/pages\/27564\/revisions\/27571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/media\/22206"}],"wp:attachment":[{"href":"https:\/\/www.neolife.com.tr\/sr\/wp-json\/wp\/v2\/media?parent=27564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}